To determine the efficacy of a secondary HPT treatment regimen including cinacalcet compared to a treatment regimen not including cinacalcet (placebo) on the composite of time to all-cause mortality or first non-fatal cardiovascular event (myocardial infarction [MI], hospitalization for unstable angina, heart failure [HF], or peripheral vascular event).
Status: Closed for enrollment, follow-up phase
Phone:212-263-7300
